Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Othman Al-Sawaf, MD, and Lydia Scarfò, MD, discuss key trials presented at EHA 2022 evaluating the use of BTK inhibitors in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). The discussion includes analyses of:
Dep I of Internal Medicine
University Hospital of Cologne
Università Vita-Salute San Raffaele
Strategic Research Program on CLL
This program has been made available online.
Experts address audience questions from a live symposium on AML treatment strategies and future therapy directions, from Clinical Care Options (CCO)
Clinical Care Options (CCO): Expertos repasan los principales datos sobre LLC y LCM de las juntas de ASCO, EHA, la Conferencia Pan-Pacífico sobre Linfomas, ESMO y SOHO de 2022
Downloadable resource designed to serve as a helpful guide for healthcare professionals on newer therapies for patients with follicular lymphoma, from Clinical Care Options (CCO)
Downloadable slideset on recent advances in the clinical management of patients with CLL, from Clinical Care Options (CCO)